Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil

Several COVID-19 vaccines have shown good efficacy in clinical trials, but there remains uncertainty about the efficacy of vaccines against different variants. Here, we investigate the efficacy of ChAdOx1 nCoV-19 (AZD1222) against symptomatic COVID-19 in a post-hoc exploratory analysis of a Phase 3...

Descripción completa

Detalles Bibliográficos
Autores principales: Clemens, Sue Ann Costa, Folegatti, Pedro M., Emary, Katherine R. W., Weckx, Lily Yin, Ratcliff, Jeremy, Bibi, Sagida, De Almeida Mendes, Ana Verena, Milan, Eveline Pipolo, Pittella, Ana, Schwarzbold, Alexandre V., Sprinz, Eduardo, Aley, Parvinder K., Bonsall, David, Fraser, Christophe, Fuskova, Michelle, Gilbert, Sarah C., Jenkin, Daniel, Kelly, Sarah, Kerridge, Simon, Lambe, Teresa, Marchevsky, Natalie G., Mujadidi, Yama F., Plested, Emma, Ramasamy, Maheshi N., Simmonds, Peter, Golubchik, Tanya, Voysey, Merryn, Pollard, Andrew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494913/
https://www.ncbi.nlm.nih.gov/pubmed/34615860
http://dx.doi.org/10.1038/s41467-021-25982-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494913/
https://www.ncbi.nlm.nih.gov/pubmed/34615860
http://dx.doi.org/10.1038/s41467-021-25982-w

Ejemplares similares